Skip to content
10-K

Annual Report

Intercept Pharmaceuticals, Inc.

0001558370-23-002693

← back to feed
Filed
Mar 2, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Jan 31, 2023 41.67M sh
Shares Diluted FY 2022 · Dec 31, 2022 33.84M sh
Shares Diluted FY 2022 · Dec 31, 2021 31.89M sh
Shares Diluted FY 2022 · Dec 31, 2020 32.97M sh
Capex FY 2022 · Dec 31, 2022 $568K
Capex FY 2022 · Dec 31, 2021 $397K
Capex FY 2022 · Dec 31, 2020 $3.89M
Operating Cash Flow FY 2022 · Dec 31, 2022 −$26.78M
Operating Cash Flow restated FY 2022 · Dec 31, 2021 −$41.07M
Operating Cash Flow restated FY 2022 · Dec 31, 2020 −$171.86M
Long Term Debt FY 2022 · Dec 31, 2022 $223.1M
Long Term Debt FY 2022 · Dec 31, 2021 $539.78M
Short Term Debt FY 2022 · Dec 31, 2022 $109.57M
Cash And Equivalents FY 2022 · Dec 31, 2022 $50.52M
Cash And Equivalents FY 2022 · Dec 31, 2021 $84.71M
Cash And Equivalents FY 2022 · Dec 31, 2020 $58.15M
Stockholders Equity FY 2022 · Dec 31, 2022 $93.08M
Stockholders Equity FY 2022 · Dec 31, 2021 −$183.96M
Stockholders Equity FY 2022 · Dec 31, 2020 −$166.85M
Stockholders Equity FY 2022 · Dec 31, 2019 $51.56M
Current Liabilities FY 2022 · Dec 31, 2022 $230.08M
Current Liabilities restated FY 2022 · Dec 31, 2021 $168.16M
Total Liabilities FY 2022 · Dec 31, 2022 $460.63M
Total Liabilities FY 2022 · Dec 31, 2021 $710.99M
Current Assets FY 2022 · Dec 31, 2022 $540.13M
Current Assets restated FY 2022 · Dec 31, 2021 $508.02M
Total Assets FY 2022 · Dec 31, 2022 $553.71M
Total Assets FY 2022 · Dec 31, 2021 $527.02M
Eps Diluted FY 2022 · Dec 31, 2022 −$0.50
Eps Diluted FY 2022 · Dec 31, 2022 $6.56
Eps Diluted FY 2022 · Sep 30, 2022 $7.80
Eps Diluted FY 2022 · Jun 30, 2022 −$0.25
Eps Diluted FY 2022 · Mar 31, 2022 −$0.58
Eps Diluted FY 2022 · Dec 31, 2021 −$1.23
Eps Diluted FY 2022 · Dec 31, 2021 −$2.87
Eps Diluted FY 2022 · Sep 30, 2021 −$0.11
Eps Diluted FY 2022 · Jun 30, 2021 −$0.33
Eps Diluted FY 2022 · Mar 31, 2021 −$1.22
Eps Diluted FY 2022 · Dec 31, 2020 −$8.34
Eps Basic FY 2022 · Dec 31, 2022 −$0.50
Eps Basic FY 2022 · Dec 31, 2022 $6.56
Eps Basic FY 2022 · Sep 30, 2022 $7.80
Eps Basic FY 2022 · Jun 30, 2022 −$0.25
Eps Basic FY 2022 · Mar 31, 2022 −$0.58
Eps Basic FY 2022 · Dec 31, 2021 −$1.23
Eps Basic FY 2022 · Dec 31, 2021 −$2.87
Eps Basic FY 2022 · Sep 30, 2021 −$0.11
Eps Basic FY 2022 · Jun 30, 2021 −$0.33
Eps Basic FY 2022 · Mar 31, 2021 −$1.22
Eps Basic FY 2022 · Dec 31, 2020 −$8.34
Sga Expense FY 2022 · Dec 31, 2022 $176.3M
Sga Expense restated FY 2022 · Dec 31, 2021 $177.49M
Sga Expense restated FY 2022 · Dec 31, 2020 $260.5M
Rd Expense FY 2022 · Dec 31, 2022 $176.64M
Rd Expense restated FY 2022 · Dec 31, 2021 $182.75M
Rd Expense restated FY 2022 · Dec 31, 2020 $189.03M
Net Income FY 2022 · Dec 31, 2022 −$20.82M
Net Income FY 2022 · Dec 31, 2022 $221.82M
Net Income FY 2022 · Sep 30, 2022 $267.45M
Net Income FY 2022 · Jun 30, 2022 −$7.53M
Net Income FY 2022 · Mar 31, 2022 −$17.29M
Net Income FY 2022 · Dec 31, 2021 −$36.28M
Net Income FY 2022 · Dec 31, 2021 −$91.43M
Net Income FY 2022 · Sep 30, 2021 −$3.63M
Net Income FY 2022 · Jun 30, 2021 −$11.09M
Net Income FY 2022 · Mar 31, 2021 −$40.42M
Net Income FY 2022 · Dec 31, 2020 −$274.88M
Operating Income FY 2022 · Dec 31, 2022 −$18.91M
Operating Income FY 2022 · Dec 31, 2022 −$68.22M
Operating Income FY 2022 · Sep 30, 2022 −$9.84M
Operating Income FY 2022 · Jun 30, 2022 −$13.04M
Operating Income FY 2022 · Mar 31, 2022 −$26.43M
Operating Income FY 2022 · Dec 31, 2021 −$29.18M
Operating Income restated FY 2022 · Dec 31, 2021 −$100.41M
Operating Income FY 2022 · Sep 30, 2021 −$19.48M
Operating Income FY 2022 · Jun 30, 2021 −$13.15M
Operating Income FY 2022 · Mar 31, 2021 −$38.59M
Operating Income restated FY 2022 · Dec 31, 2020 −$229.73M
Cost Of Revenue FY 2022 · Dec 31, 2022 $984K
Cost Of Revenue restated FY 2022 · Dec 31, 2021 $1.21M
Cost Of Revenue restated FY 2022 · Dec 31, 2020 $2.35M
Revenue FY 2022 · Dec 31, 2022 $77.22M
Revenue FY 2022 · Dec 31, 2022 $285.71M
Revenue FY 2022 · Sep 30, 2022 $77.59M
Revenue FY 2022 · Jun 30, 2022 $71.76M
Revenue FY 2022 · Mar 31, 2022 $59.15M
Revenue FY 2022 · Dec 31, 2021 $68.63M
Revenue restated FY 2022 · Dec 31, 2021 $260.75M
Revenue FY 2022 · Sep 30, 2021 $66.64M
Revenue FY 2022 · Jun 30, 2021 $68.18M
Revenue FY 2022 · Mar 31, 2021 $57.3M
Revenue restated FY 2022 · Dec 31, 2020 $233.97M
Stock Repurchased FY 2022 · Dec 31, 2021 $75.83M